FcγRIIa (CD32): A potential marker defining susceptibility to localized juvenile periodontitis

Journal of Periodontology

Volumn 67, Issue 3 SUPPL., 1996, Pages 323-331

  Wilson, Mark E ^a   Kalmar, John R ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Actinobacillus actinomycetemcomitans pathogenesis; Antibodies, bacterial; Igg; Periodontitis, early onset epidemiology; Periodontitis, early onset microbiology; Periodontitis, juvenile microbiology; Racial factors; Receptors, IgG

Indexed keywords

EID: 0000981036     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1996.67.3s.323     Document Type: Article

References (75)

1. Caton J. Periodontal diagnosis and diagnostic aids. Proceedings of the World Workshop in Clinical Periodontics. Chicago: The American Academy of Periodontology: 1989:I-1.
2. Zambon JJ. Actinobactllus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985;12:1-20.
3. Löe H, Brown LJ. Early onset periodontitis in the United States of America. J Periodontol 1991;62:608-616.
4. Melvin WL, Sandifer JB, Gray JL. The prevalence and sex ratio of juvenile periodontitis in a young racially mixed population. J Periodontol 1991;62:330-334.
5. Neely AL. Prevalence of juvenile periodontitis in a circumpubertal population. J Clin Periodontol 1992;19:367-372.
6. Butler J. A familial pattern of juvenile periodontitis (periodontosis). J Periodontol 1969;40:115-118.
7. Beaty T, Boughman J, Yang P, Astemborski J, Suzuki J. Genetic analysis of juvenile periodontitis in families ascertained through an affected proband. Am J Hum Genet 1987;40:443-452.
8. Saxén L. Heredity of juvenile periodontitis. J Clin Periodontol 1980;7:276-288.
9. Schenkein HA. Genetics of early-onset periodontal diseases. In: Genco R, Hamada S, Lehner T, McGhee J, Mergenhagen S, eds. Molecular Pathogenesis of Periodontal Disease. Washington, D.C.: American Society for Microbiology; 1994:373-386.
10. Hart TC. Genetic considerations of risk in human periodontal disease. Curr Opin Periodontol 1994:3-11.
11. Saxén L, Koskimies S. Juvenile periodontitis - no linkage with HLA-antigens. J Periodont Res 1984;19:441-444.
12. Sofaer J. Genetic approaches in the study of periodontal disease. J Clin Periodontol 1990;17:401-408.
13. Miyasaki KT. The neutrophil: Mechanisms of controlling periodontal bacteria. J Periodontol 1991;62:761-774.
14. Genco RJ, Van Dyke TE, Levine MJ, Nelson RD, Wilson ME. Molecular factors influencing neutrophil defects in periodontal disease. J Dent Res 1986;65:1379-1391.
15. Ranney RR, Yanni NR, Burmeister JA, Tew JG. Relationship between attachment loss and precipitating serum antibody to Actinobacillus actinomycetemcomitans in adolescents and young adults having severe periodontal destruction. J Periodontol 1982;53:1-7.
16. Ebersole JL, Taubman MA, Smith DJ, Genco RJ, Frey DE. Human immune responses to oral micro-organisms. I. Association of localized juvenile periodontitis (LJP) with serum antibody responses to Actinobacillus actinomycetemcomitans. Clin Exp Immunol 1982;47: 43-52.
17. Ebersole JL, Taubman MA, Smith DJ, Hammond BF, Frey DE. Human immune responses to oral microorganisms. II. Serum antibody responses to antigens from Actinobacillus actinomycetemcomitans and the correlation with localized juvenile periodontitis. J Clin Immunol 1983;3:321-331.
18. Tsai C-C, McArthur WP, Baehni PC, Evian C, Genco R, Taichman NS. Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis. J Clin Periodontol 1981;8:338-348.
19. Watanahe H, Marsh PD, Ivanyi L. Antigens of Actinobacillus actinomycetemcomitans identified by immunoblotting with sera from patients with localized human juvenile periodontitis and generalized severe periodontitis. Arch Oral Biol 1989;34:649-656.
20. Wilson ME. IgG antibody response of localized juvenile periodontitis patients to the 29 kilodalton outer membrane protein of Actinobacillus actinomycetemcomitans. J Periodontol 1991;62:211-218.
21. Farida R, Wilson M, Ivanyi L. Serum IgG antibodies to lipopolysaccharides in various forms of periodontal disease in man. Arch Oral Biol 1986;31:711-715.
22. Califano JV, Schenkein HA, Tew JG. Immunodominant antigen of Actinobacillus actinomycetemcomitans Y4 in high-responder patients. Infect Immun 1989;57:1582-1589.
23. Sims TJ, Moncla BJ, Darveau RP, Page RC. Antigens of Actinobacillus actinomycetemcomitans recognized by patients with juvenile periodontitis and periodontally normal subjects. Infect Immun 1991;59:913-924.
24. Wilson ME, Schifferle RE. Evidence that the serotype b antigenic determinant of Actinobacillus actinomycetemcomitans Y4 resides in the polysaccharide moiety of lipopolysaccharide. Infect Immun 1991;59:1544-1551.
25. Page RC, Sims TJ, Engel LD, et al. The immunodominant outer membrane antigen of Actinobacillus actinomycetemcomitans is located in the serotype-specific high-molecular-mass carbohydrate moiety of lipopolysaccharide. Infect Immun 1991;59:3451-3462.
26. Gunsolley JC, Burmeister JA, Tew JG, Best AM, Ranney RR. Relationship of serum antibody to attachment level patterns in young adults with juvenile periodontitis or generalized severe periodontitis. J Periodontol 1987;58:314-320.
27. Sundqvist G, Johansson E. Bactericidal effect of pooled human serum on Bacteroides melaninogenicus, Bacteroides asaccharolyticus and Actinobacillus actinomycetemcomitans. Scand J Dent Res 1982;90:29-36.
28. Wilson ME, Genco RJ. The role of antibody, complement and neutrophils in host defense against Actinobacillus actinomycetemcomitans. Immunol Invest 1989;18:187-209.
29. Miyasaki KT, Wilson ME, Brunetti AJ, Genco RJ Oxidative and nonoxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils. Infect Immun 1986;53:154-160.
30. Baker PJ, Wilson ME. Opsonic IgG antibody against Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 1989;4:98-105.
31. Taichman NS, Tsai C-C, Shenker BJ, Boehringer H. Neutrophil interactions with oral bacteria as a pathogenic mechanism in periodontal diseases. In: Weissmann G, eds. Advances in Inflammation Research, vol 8. New York: Raven Press; 1984:113-142.
32. Tsai C-C, Taichman NS Dynamics of infection by leukotoxic strains of Actinobacillus actinomycetemcomitans in juvenile periodontitis. J Clin Periodontol 1986;11:330-331.
33. Gunsolley JC, Tew JG, Gooss CM, Burmeister JA, Schenkein HA. Effects of race and periodontal status on antibody reactive with Actinobacillus actinomycetemcomitans strain Y4. J Periodont Res 1988,23:303-307.
34. Hamilton RG. Human IgG subclass measurements in the clinical laboratory. Clin Chem 1987;33:1707-1725.
35. Smith TF. IgG subclasses. Adv Pediatr 1992;39:101-126.
36. Amir J, Scott M, Nahm M, Granoff D. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. J Infect Dis 1990;162:163-171.
37. Bredius RG, Driedijk PC, Schouten MF, Weening RS, Out TA Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid. Infect Immun 1992;60:4838-4847.
38. Jefferis R, Kumararatne DS. Selective IgG subclass deficiency: Quantification and clinical relevance. Clin Exp Immunol 1990;81: 357-367.
39. Ling TY, Sims TJ, Chen HA, et al. Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis, J Clin Immunol 1993;13:100-111.
40. Wilson ME, Hamilton RG. Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide. Infect Immun 1992;60:1806-1812.
41. Lu H, Califano JV, Schenkein HA, Tew JG. Immunoglobulin class and subclass distribution of antibodies reactive with the immunodominant antigen of Actinobacillus actinomycetemcomitans serotype b. Infect Immun 1993;61:2400-2407.
42. Hammarström L, Smith CI. IgG subclasses in bacterial infections. Monogr Allergy 1986;19:122-133.
43. Hammarström L, Smith CI. IgG subclass changes in response to vaccination. Monogr Allergy 1986;19:241-252.
44. Wilson ME, Hamilton RG. Immunoglobulin G subclass response of juvenile periodontitis subjects to principal outer membrane proteins of Actinobacillus actinomycetemcomitans. Infect Immun 1995;63: 1062-1069.
45. Lu H, Wang M, Gunsolley JC, Schenkein HA, Tew JG. Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals. Infect Immun 1994;62:1677-1682.
46. van de Winkel JG, Anderson CL. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol 1991;49:511-524.
47. van de Winkel JG, Capel PJ. Human IgG Fc receptor heterogeneity: Molecular aspects and clinical implications. Immunol Today 1993;14:215-221.
48. Buckle AM, Hogg N. The effect of IFN-gamma and colony-stimulating factors on the expression of neutrophil cell membrane receptors. J Immunol 1989;143:2295-2301.
49. Gericke GH, Ericson SG, Pan L, et al. Mature polymorphonuclear leukocytes express high-affinity receptors for IgG (FcγRI) after stimulation with granulocyte colony-stimulating factor (G-CSF). J Leukoc Biol 1995;57:455-461.
50. Burton DR. Immunoglobulin G: functional sites. Mol Immunol 1985;22:161-206.
51. Karas SP, Rosse WF, Kurlander RJ. Characterization of the IgG-Fc receptor on human platelets. Blood 1982;60:1277-1282.
52. Huizinga TW, van der School CE, Jost C, et al. PI-linked FcRIII is released on stimulation of neutrophils. Nature 1988;333:667-669.
53. Huizinga TW, van Kemenade F, Koenderman L, et al. The 40-kDa Fcγ receptor (FcγRII) on human neutrophils is essential for the IgG-induced respiratory burst and IgG-induced phagocytosis. J Immunol 1989;142:2365-2369.
54. Bredius RG, de Vries CE, Troelstra A, et al. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type b opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFcγRIIa polymorphism to IgG2. J Immunol 1993;151:1463-1472.
55. Salmon JE, Brogle NL, Edberg JC, Kimberly RP. Fcγ receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fcγ receptor II. J Immunol 1991;146: 997-1004.
56. Tax WJ, Willems HW, Reekers PP, Capel PJ, Koene RA. Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 1983;304:445-447.
57. Abo T, Tilden AB, Balch CM, Kumagai K, Troup GM, Cooper MD. Ethnic differences in the lymphocyte proliferative response induced by a murine Ig1 antibody, Leu-4, to the T3 molecule. J Exp Med 1984;160:303-309.
58. Anderson CL, Ryan DH, Looney RJ, Leary PC. Structural polymorphism of the human monocyte 40 kitodalton Fc receptor for IgG. J Immunol 1987;138:2254-2256.
59. Warrnerdam PA, van de Winkel JG, Gosselin EJ, Capel PJ. Molecular basis for a polymorphism on human Fcγ receptor II (CD32). J Exp Med 1990;172:19-25.
60. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding. J Immunol 1991;147:1338-1343.
61. Parren PW, Warmerdam PA, Boeije LC, et al. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest 1992;90:1537-1546.
62. Warmerdam PA, Parren PW, Vlug A, et al. Polymorphism of the human Fcγ receptor II (CD32): Molecular basis and functional aspects. Immunobiol 1992;185:175-182.
63. Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 1992;89:1274-1281.
64. Sanders LA, Feldman RG, Voorhorst-Ogink MM, et al. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 1995;63:73-81.
65. Hulett MD, Witort E, Brinkworth RI, McKenzie IF, Hogarth PM. Identification of the IgG binding site of the human low affinity receptor for IgG FcγRII. Enhancement and ablation of binding by site-directed mutagenesis. J Biol Chem 1994;269:15287-15293.
66. Wilson ME, Bronson PM, Hamilton RG. Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetem-comitans. Infect Immun 1995;63:1070-1075.
67. Cutler CW, Kalmar JR, Arnold RR. Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G. Infect Immun 1991;59:2097-2104.
68. Kalmar JR. Measurement of opsonic phagocytosis by human polymorphonuclear neutrophils. Methods Enzymol 1994;236:108-119.
69. Bredius RG, Derkx BH, Fijen CA, et al. Fcγ receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994;170:848-853.
70. Sanders LA, van de Winkel JG, Rijkers GT, et al. Fcγ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 1994,170:854-861.
71. Osborne JM, Chacko GW, Brandt JT, Anderson CL. Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allelic specific oligonucleotide probes. J Immunol Methods 1994;173:207-217.
72. Nagata M, Hara T, Aoki T, et al. Inherited deficiency of ninth component of complement: An increased risk of meningococcal meningitis. J Pediatr 1989;114:260-264.
73. Musser JM, Kroll JS, Granoff DM, et al. Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis 1990;12:75-111.
74. Parke J, Schneerson R, Robbins J. The attack rate, age incidence, racial distribution, and case fatality of Haemophilus influenzae type b meningitis in Mecklenburg County, North Carolina. J Pediatr 1972;81:765-769.
75. Leino L, Hurttia HM, Sorvajarvi K, Sewon LA. Increased respiratory burst activity is associated with normal expression of IgG-Fc-receptors and complement receptors in peripheral neutrophils from patients with juvenile periodontitis. J Periodont Res 1994;29:179-184